This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Recombinant tissue plasminogen activator (rt-PA) is effective for treating acute ischemic stroke.1 Because of the very brief time window, it is often not possible to investigate stroke etiology before administering rt-PA. There have been a number of case reports of thrombolytic therapy in patients suspected of having acute myocardial infarction who in actuality had an aortic dissection.2,3 The use of thrombolytics to treat ischemic stroke caused by an aortic dissection has not been documented. We report a patient who presented with symptoms consistent with acute ischemic stroke and was given rt-PA. Further investigation demonstrated an aortic dissection as the cause of his stroke.
Case report.
A 54-year-old man presented after his wife heard him fall and found him on the floor, nonverbal, unable to move his right side. There was no history of chest or back pain. Past medical history was significant for hypertension, tobacco abuse, borderline diabetes mellitus, and recent sinus surgery.
On examination, he was afebrile with a blood pressure …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg